Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional properties

Danica E. Johnson, Joshua D. Rosenblat

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (10)

  1. Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer. 2024-11-01 · Expand citations
  2. Psilocybin desynchronizes the human brain. 2024-08-01 · Expand citations
  3. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. 2023-01-01 · Expand citations
  4. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. 2021-08-18 · Expand citations
  5. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  6. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  7. OpenAlex W2552814605
  8. OpenAlex W3120778817
  9. OpenAlex W4387521434
  10. OpenAlex W4396939835

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.